Immutep Limited Employee Directory

Biotechnology ResearchNew South Wales, Australia11-50 Employees

Immutep is a late-stage clinical biotechnology company developing novel LAG-3 immunotherapies to fight cancer and autoimmune disease. We are pioneers in the understanding and advancement of therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), and harness its unique ability to stimulate or suppress the immune response. Our diversified product portfolio includes eftilagimod alpha, a proprietary soluble LAG-3 protein and MHC Class II agonist in oncology, and IMP761, the world's first LAG-3 agonist designed to target the underlying causes of autoimmune diseases. Immutep is dedicated to leveraging its expertise to bring innovative treatment options to patients in need and to maximise value for shareholders. 

Immutep is listed on the Australian Securities Exchange (IMM), and on the NASDAQ (IMMP) in the United States.

Find Immutep Limited employees' phone numbers or email addresses

Immutep Limited Global Highlights

Europe
32

Germany
22
Hungary
5
France
3
Netherlands
1
Switzerland
1

Oceania
23

Australia
23

Asia
3

China
2
India
1

North America
3

United States Of America
2
Mexico
1

Africa
1

Niger
1

Immutep Limited's Leadership

D. M.
Chief Operating Officer
Mobile Phone
Email
F. T.
Chief Scientific Officer
Mobile Phone
Email
M. V.
Ceo
Mobile Phone
Email
F. T.
Cso And Cmo
Mobile Phone
Email
M. V.
Cfo
Mobile Phone
Email
R. J. H.
Chairman Of The Board
Mobile Phone
Email
C. M.
Svp Regulatory & Strategy
Mobile Phone
Email
L. B.
Sr.Director Head Of Clinical Operations
Mobile Phone
Email

Contact profiles from Immutep Limited

Name

Title

Contact Info

Location

Last Update

D. F.
Finance Director And Assistant Company Secretary
Mobile Phone
Email
AustraliaNew South Wales
Dec 09, 2024
R. R.
Director Regulatory Affairs
Mobile Phone
Email
Dec 09, 2024
D. W.
Associate Medical Director
Mobile Phone
Email
Hungary
Dec 09, 2024
C. J.
Director Of Manufacturing
Mobile Phone
Email
GermanyBerlin
Dec 09, 2024
L. P.
Associate Medical Director
Mobile Phone
Email
Hungary
Dec 09, 2024
S. D.
Senior Finance Manager
Mobile Phone
Email
GermanyBerlin
Feb 15, 2024
B. K.
Qa-Manager
Mobile Phone
Email
GermanyBerlin
Nov 03, 2024
D. V.
Senior Business Development Manager
Mobile Phone
Email
GermanyBerlin
Dec 09, 2024
I. N. B. C. F.
Company Secretary & Senior Finance Manager
Mobile Phone
Email
AustraliaNew South Wales
Nov 03, 2024
J. E.
Senior Clinical Trial Manager
Mobile Phone
Email
GermanyNorth Rhine-Westphalia
Dec 09, 2024

Frequently Asked Questions

What is Immutep Limited known for?

Immutep Limited operates in the Biotechnology Research industry. The company's main headquarters is located in Level 33, Australia Square 264 George Street Sydney, NSW 2000 AU. Explore Immutep Limited's company overview page for more information.

What is Immutep Limited's most common email format?

Immutep Limited employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more Immutep Limited email formats with LeadIQ.

How many employees does Immutep Limited have currently?

Immutep Limited has approximately 49 employees as of November 2024. These team members are located across 5 continents, including EuropeOceaniaAsia.

Who are Immutep Limited's key employees and leadership?

As of November 2024, Immutep Limited's key employees include:

Chief Operating Officer: D. M.
Chief Scientific Officer: F. T.
Ceo: M. V.
Cso And Cmo: F. T.
Cfo: M. V.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking